Research Frontiers (REFR) EBITDA Margin (2016 - 2026)

Research Frontiers has disclosed EBITDA Margin across 11 years of filings, most recently posting 389.1% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 389.1%, down 34630.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 347.24% (down 27064.0% YoY), and the FY2025 annual result was 190.16%, down 8220.0% from the prior year.
• EBITDA Margin came in at 389.1% for Q1 2026 at Research Frontiers, up from 1072.53% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 23.72% in Q2 2024 to a low of 1072.53% in Q4 2025.
• The 5-year median for EBITDA Margin is 313.02% (2023), against an average of 348.02%.
• Across the five-year window, EBITDA Margin surged 58522 bps in 2023 and sank 72211 bps in 2025, its largest moves.
• Research Frontiers' EBITDA Margin stood at 631.31% in 2022, then surged by 74 bps to 161.86% in 2023, then slumped by 116 bps to 350.42% in 2024, then slumped by 206 bps to 1072.53% in 2025, then soared by 64 bps to 389.1% in 2026.
• The last three EBITDA Margin figures came in at 389.1% (Q1 2026), 1072.53% (Q4 2025), and 84.56% (Q3 2025), per Business Quant data.